The Business Location’s Advantages

Strong structures and extensive innovative strength. The excellent conditions of the BioPharma Cluster South Germany make it an attractive hub for innovative companies and investors.

European Leader in the Biopharmacy Sector

The region’s biotechnology companies research and develop the megatrends of tomorrow. About 100 local companies design therapeutic or diagnostic procedures and do research in the field of personalised medicine. But the region is not only a biotechnology leader. A balanced mix of top-positioned industries with a wide range of expertise ensures a sustainable and secure business location.

Synergies Create Innovation

Numerous rankings prove that the BioPharma Cluster is one of the top regions nationwide. According to the Innovation Index of the State Statistical Office of Baden-Württemberg, the Danube-Iller region is one of the top three most innovative regions in the German federal state of Baden-Württemberg.

An economic and innovation strategy actively promotes the cluster’s development. Biotechnology is clearly prioritised and politically supported as a technology of the future.

The state’s cluster policy creates innovation-friendly structures, allowing regional potential to develop and international competitiveness to be secured.

Located in the Danube-Iller region, the cluster benefits enormously from the synergy potential of Baden-Württemberg and Bavaria’s economic strength. It supports a sustainable business location through joint development potential from a single source.

Popular for Living and Working

A look at the structural data shows that the region is young, dynamic and economically strong. With the lowest unemployment rate in the country, an above-average purchasing power and a young age structure, the BioPharma Cluster underlines its claim to be Germany's future region.

In the 2018 City Level Ranking in German news magazine “WirtschaftsWoche”, the city of Ulm took eighth place in categories "Economic and Labour Strength" and "Living and Quality of Life".

According to recent surveys by the Ulm Chamber of Commerce and Industry, 80 percent of the local companies would recommend Ulm as a business location. In particular, companies and investors appreciate the cluster’s excellent SME support. In the past few years, almost every third company expanded in terms of space.

Future Research at Colleges and Universities

The BioPharma Cluster comes with modern, science-oriented infrastructure featuring renowned research institutions. Industrial locations such as the Ulm Science Park promote networking between industry and science.

A highly innovative research and education landscape is actively driving forward the future of biotechnology. Biberach University of Applied Sciences, Ulm Technical University of Applied Sciences and Ulm University are strong research and collaboration partners for numerous companies in the BioPharma Cluster.

More articles

Funding Programmes

Diverse Funding Programmes in the BioPharma Cluster South Germany

Funding programmes from the German federal government, its federal states and the EU fund start-ups and innovative companies who provide progressive projects.

Site Selection Consultation

Extensive Location Expertise in the BioPharma Cluster South Germany

The BioPharma Cluster South Germany offers extensive expertise and experience to investors and companies for them to successfully establish themselves in the region.

[Translate to "EN"]

Biotechnology Centre

TFU BiotechnologyCentre in the BioPharma Cluster South Germany

The TFU Start-Up and Innovation Centre’s Biotechnology Centre of the Ulm / Neu-Ulm region helps start-ups as well as established companies implement innovation processes.